Industry
Sponsored by
An interview to SynBalance Marketing Manager, Silva Castegnaro on the latest clinically backed solutions shaping the future of biotics world.
Genetic factors can influence tumor-associated microbes, offering insights into colorectal cancer progression and potential therapeutic targets.
TCA can help to manage IBD by supporting the gut barrier and influencing microbiota composition.
With nearly half of European consumers taking supplements for general wellbeing, the potential for targeted innovation is vast, especially on “biotics” products.
Gastroenterology
Sponsored by
Postbiotics can selectively enhance beneficial microbes, offering a safe and effective microbiome-support strategy.
EMIH’s new members bring cutting-edge expertise in biotech, diagnostics, and patient advocacy, accelerating progress in microbiome-based healthcare.
The findings of a recent study highlight the importance of early-life gut microbes in shaping lung health and add to evidence that microbiota composition can influence asthma risk.
Altered gut bacteria may contribute to fibromyalgia and modifying the gut microbiota could offer a promising approach to reduce symptoms of the condition.
Gynecology, Industry
Sponsored by
Ana Nunes, Business Unit Director, on Zinereo’s science-backed mission to transform fertility through the microbiome.
A term big enough to capture the profound transformation underway as microbial intelligence moves from fringe fascination to fundamental force.
